NTR vs. BMY
Compare and contrast key facts about Nutrien Ltd. (NTR) and Bristol-Myers Squibb Company (BMY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NTR or BMY.
Correlation
The correlation between NTR and BMY is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
NTR vs. BMY - Performance Comparison
Loading data...
Key characteristics
NTR:
0.17
BMY:
0.25
NTR:
0.48
BMY:
0.56
NTR:
1.06
BMY:
1.07
NTR:
0.09
BMY:
0.14
NTR:
0.34
BMY:
0.78
NTR:
16.00%
BMY:
8.52%
NTR:
27.78%
BMY:
31.47%
NTR:
-58.18%
BMY:
-70.62%
NTR:
-44.15%
BMY:
-37.21%
Fundamentals
NTR:
$27.78B
BMY:
$93.23B
NTR:
$1.06
BMY:
$2.78
NTR:
53.75
BMY:
16.48
NTR:
1.13
BMY:
2.26
NTR:
1.12
BMY:
1.96
NTR:
1.18
BMY:
5.16
NTR:
$25.54B
BMY:
$47.64B
NTR:
$7.55B
BMY:
$31.43B
NTR:
$4.03B
BMY:
$16.18B
Returns By Period
In the year-to-date period, NTR achieves a 29.81% return, which is significantly higher than BMY's -17.22% return.
NTR
29.81%
10.03%
26.83%
4.80%
16.72%
N/A
BMY
-17.22%
-8.38%
-19.97%
7.88%
-3.02%
-0.74%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NTR vs. BMY — Risk-Adjusted Performance Rank
NTR
BMY
NTR vs. BMY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Nutrien Ltd. (NTR) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
NTR vs. BMY - Dividend Comparison
NTR's dividend yield for the trailing twelve months is around 3.77%, less than BMY's 5.33% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NTR Nutrien Ltd. | 3.77% | 4.83% | 3.76% | 2.63% | 2.45% | 3.74% | 3.67% | 3.47% | 0.00% | 0.00% | 0.00% | 0.00% |
BMY Bristol-Myers Squibb Company | 5.33% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% | 2.46% |
Drawdowns
NTR vs. BMY - Drawdown Comparison
The maximum NTR drawdown since its inception was -58.18%, smaller than the maximum BMY drawdown of -70.62%. Use the drawdown chart below to compare losses from any high point for NTR and BMY. For additional features, visit the drawdowns tool.
Loading data...
Volatility
NTR vs. BMY - Volatility Comparison
The current volatility for Nutrien Ltd. (NTR) is 7.34%, while Bristol-Myers Squibb Company (BMY) has a volatility of 11.36%. This indicates that NTR experiences smaller price fluctuations and is considered to be less risky than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
NTR vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between Nutrien Ltd. and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NTR vs. BMY - Profitability Comparison
NTR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Nutrien Ltd. reported a gross profit of 1.32B and revenue of 5.10B. Therefore, the gross margin over that period was 25.9%.
BMY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Bristol-Myers Squibb Company reported a gross profit of 8.17B and revenue of 11.20B. Therefore, the gross margin over that period was 72.9%.
NTR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Nutrien Ltd. reported an operating income of 226.00M and revenue of 5.10B, resulting in an operating margin of 4.4%.
BMY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Bristol-Myers Squibb Company reported an operating income of 3.52B and revenue of 11.20B, resulting in an operating margin of 31.4%.
NTR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Nutrien Ltd. reported a net income of 11.00M and revenue of 5.10B, resulting in a net margin of 0.2%.
BMY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Bristol-Myers Squibb Company reported a net income of 2.46B and revenue of 11.20B, resulting in a net margin of 21.9%.